tiprankstipranks
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics (ALLR) Income Statement

372 Followers

Allarity Therapeutics Income Statement

Last quarter (Q4 2025), Allarity Therapeutics's total revenue was $320.00K, an increase of Infinity% from the same quarter last year. In Q4, Allarity Therapeutics's net income was $-3.37M. See Allarity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Mar 22
Total Revenue
$ 320.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 320.00K$ 0.00$ -37.00K$ -120.00K$ -106.00K
Operating Expenses
$ 12.93M$ 27.24M$ 17.13M$ 34.46M$ 26.56M
Depreciation and Amortization
$ -13.00K$ 9.00K$ 37.00K$ 60.00K$ 106.00K
EBITDA
$ -11.05M$ -24.23M$ -11.28M$ -17.30M$ -25.77M
Operating Income
$ -12.61M$ -27.24M$ -17.13M$ -34.46M$ -26.56M
Other Income/Expenses
$ 1.37M$ 2.35M$ 5.31M$ 16.88M$ 41.00K
Pretax Income
$ -11.23M$ -24.90M$ -11.82M$ -17.58M$ -26.52M
Net Income
$ -11.23M$ -24.52M$ -11.90M$ -16.06M$ -26.65M
Per Share Metrics
Basic EPS
$ -0.78$ -15.79$ -6.03K$ -31.80K$ -79.07K
Diluted EPS
$ -0.78$ -15.79$ -6.03K$ -31.80K$ -79.07K
Weighted Average Shares Outstanding
14.38M 1.61M 3.32M 11.34K 7.57K
Weighted Average Shares Outstanding (Diluted)
14.38M 1.61M 3.32M 11.34K 7.57K
Currency in USD

Allarity Therapeutics Earnings and Revenue History